Immunotherapy in mCRC

MEET THE EXPERTS ALL PROGRAMMES DEVELOPED COLLABORATIONS CONTACT

Immunotherapy in mCRC

Assoc. Prof. Gerald Prager

Associate Professor Dr Gerald Prager, from the Medical University of Vienna (Austria) has summarised the insights from clinical data on immunotherapy in mCRC (2015).

Assoc. Prof. Gerald Prager

Medical Oncologist

Medical University of Vienna

Austria

Biography Disclosures

Assoc. Prof. Gerald Prager

Medical Oncologist

Medical University of Vienna

Austria

Dr Gerald Prager is an Associate Professor of Medicine, Board Certified for Internal Medicine Board and Certified for Haematology and Medical Oncology. In 2009, he received his M.D. from the University of Vienna. Currently, Dr Prager is Director of the Colorectal Cancer Unit of the Department of Medical Oncology at the Medical University of Vienna. He is also a member of the ESMO 2014 Scientific Committee. The research interest of his lab focuses on (tumour-) angiogenesis via regulation of endothelial cell survival and migration by cell / extracellular-matrix interaction. Through his clinical training in haemato-oncology, he became a member of the sought-after group of medical researches. He achieved his expertise in international renowned labs at University of California, San Diego, the Norris Cancer Center, Los Angeles and the Department of Vascular Biology, Mississippi University for Women (MUW). His work is honoured by 19 international awards and resulted in publications in international highly renowned journals. Dr Prager’s young research group is embedded in an international cancer research campus associated with Medical University of Vienna (MUV).

Assoc. Prof. Gerald Prager has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Amgen, AstraZeneca, Bayer, BMS, Incyte, Merck Serono, MSD, Servier, Takeda

time | open 5 min | Sep 2021

This programme was made for you: your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

download resources

Download the slides

This programme was made for you: your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.

Other programmes of interest

Prof. Dimitrios Tsakiris

Dr Lars Asmis

Podcast

2 min

Cancer and Thrombosis

Sep 2023

Dr Elisa Agostinetto

Prof. Valentina Guarneri

Interactive patient case

15 min

Oral SERDs: New Endocrine Therapy Options in ER+ Advanced or Meta...

Sep 2023

Prof. Chee-Kiat Tan

Publication

5 min

Surveillance and Diagnosis of HCC in Asia: Poster Presentation at...

Sep 2023

Assoc. Prof. Gerald Prager

Video

4 min

Long-term Response in Advanced Colorectal Cancer

Sep 2023

Prof. Dr Jeroen Dekervel

Dr Amit Singal

Podcast

29 min

A New Era in Treating Patients with Advanced HCC

Sep 2023

Dr Jaume Capdevila

Asst. Prof. Mauro Cives

Micro learning

30 min

Accreditation: EACCME

Recognising, Diagnosing and Managing Neuroendocrine Tumours

Aug 2023

Acromegaly and Neuroendocrine Tumours Global Survey

Publication

15 min

Acromegaly and Neuroendocrine Tumours Global Survey

Aug 2023

Prof. Shaheenah Dawood

Assoc. Clinical Professor Rena Callahan

Podcast

74 min

Oral SERDs in ER+ Breast Cancer

Aug 2023

Dr Tracy L Stockley

Prof. David Hong

Podcast

24 min

An Introduction to Molecular Testing

Jul 2023

Dr Neal Shore

Dr Andrew J. Armstrong

Video

10 min

Clinical Implementation of Testing and PARPi as Monotherapy or in...

Aug 2023

Janet Forgenie

Video

3 min

Nursing Support for mCRPC Patients During Radiopharmaceutical Tre...

Jul 2023

Prof. Andrea Sartore-Bianchi

Video

5 min

Conference Update: ASCO and WCGIC 2023

Jul 2023

Other programmes developed by Assoc. Prof. Gerald Prager

Assoc. Prof. Gerald Prager

Medical Oncologist

Medical University of Vienna

Austria

Assoc. Prof. Gerald Prager

Video

4 min

Long-term Response in Advanced Colorectal Cancer

Sep 2023

Assoc. Prof. Gerald Prager

Assoc. Prof. Joleen Hubbard

30 min

Long-term Management of Advanced CRC: An Interactive Patient Case

Jul 2023

Dr Mansoor Raza Mirza

Dr Paolo Tarantino

Prof. Alexey V Danilov

And others...

Other

17 min

Listen to Expert Insights on Late-Breaking Data from ASCO 2023

Jun 2023

Assoc. Prof. Gerald Prager

Sven De Keersmaecker

Podcast

20 min

Podcast: flexible dosing of oral treatments in metastatic colorec...

Sep 2022

TRK fusion cancer ESMO OncologyPRO screenshot

Prof. Fernando López-Ríos

Prof. Andrea Sartore-Bianchi

Assoc. Prof. Gerald Prager

And others...

30 min

Targeting NTRK gene fusions

Sep 2019

Review paper challenging chemoresistant metastatic colorectal cancer: therapeutic strategies from the clinic and from the laboratory

Assoc. Prof. Gerald Prager

Prof. Andrea Sartore-Bianchi

Dr Guillem Argilés

5 min

Review paper challenging chemoresistant metastatic colorectal can...

2015

Review paper on challenging chemoresistant metastatic colorectal cancer

Assoc. Prof. Gerald Prager

Dr Guillem Argilés

Prof. Andrea Sartore-Bianchi

0 min

Review paper on challenging chemoresistant metastatic colorectal ...

2016

Assoc. Prof. Gerald Prager

5 min

GI CONNECT Update from ECC 2015: cancers of the liver, small inte...

2015

Assoc. Prof. Gerald Prager

5 min

GI CONNECT update from ESMO 2016: cancers of the lower GI tract

2016

Assoc. Prof. Gerald Prager

5 min

What is the role of adding aspirin in PIK3CA mutated patients?

2017

Assoc. Prof. Gerald Prager

5 min

GI CONNECT update from ESMO 2017: cancers of the lower GI tract

2017

Assoc. Prof. Joleen Hubbard

Assoc. Prof. Gerald Prager

Dr Dominik Modest

5 min

Do we need adjuvant treatment after surgical resection of colorec...

Sep 2021

Assoc. Prof. Gerald Prager

5 min

GI CONNECT update from ASCO GI 2018: cancers of the upper GI trac...

2018

Assoc. Prof. Gerald Prager

Prof. Shubham Pant

Dr Fotios Loupakis

E-learning

30 min

The SHARE Communication Framework for shared decision-making in t...

2018

Assoc. Prof. Gerald Prager

Prof. Chiara Cremolini

5 min

Treatment sequencing and flexible dosing in later-line management...

Sep 2021

Assoc. Prof. Gerald Prager

5 min

GI CONNECT Update from ASCO GI 2020: cancers of the lower GI trac...

Jan 2020

Prof. Andrea Sartore-Bianchi

Prof. Fernando López-Ríos

Assoc. Prof. Gerald Prager

5 min

NTRK gene fusions, TRK inhibitors and testing approaches BluePrin...

2019

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.